Literature DB >> 15782871

An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait.

Jeffrey N Hanna1, Greg A Smith, Bradley G McCulloch, Carmel T Taylor, Alyssa T Pyke, Dianne L Brookes.   

Abstract

OBJECTIVE: Japanese encephalitis (JE) emerged for the first time in the Torres Strait, north Australia, in 1995. The inactivated mouse-brain derived JE vaccine was offered to all residents of the outer Torres Strait Islands prior to the 1996 wet season. This study was undertaken to determine the appropriateness of the recommended three-year interval between booster doses of the vaccine.
METHODS: JE neutralising antibody was measured in residents of Badu Island for whom 30-36 months had passed since either a previous booster or the completion of the primary immunisation series.
RESULTS: Only 70 (32%) of 219 eligible individuals had protective antibodies; 50 (37%) of the adults were immune, compared with 20 (24%) of the children (odds ratio (OR) 1.93; 95% confidence interval (CI) 1.01-3.74).
CONCLUSIONS: This low level of immunity suggests that there is little in the way of natural boosting from either JE or other closely related viruses. Given the apparent low level of risk of exposure to the JE virus in the Torres Strait, and the logistical complexities involved in delivering the booster doses, the current recommendation of a three-year interval is not inappropriate. IMPLICATIONS: It would be advantageous to have a JE vaccine that is not only safer but also more immunogenic, so that it might be possible to further increase the booster dose interval.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782871     DOI: 10.1111/j.1467-842x.2005.tb00747.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  5 in total

Review 1.  Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Authors:  Nagendra R Hegde; Milind M Gore
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

2.  Development of a vaccine to prevent Japanese encephalitis: a brief review.

Authors:  Viroj Wiwanitkit
Journal:  Int J Gen Med       Date:  2009-12-29

3.  A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

Authors:  Elina O Erra; Helena Hervius Askling; Lars Rombo; Jukka Riutta; Sirkka Vene; Sutee Yoksan; Lars Lindquist; Sari H Pakkanen; Eili Huhtamo; Olli Vapalahti; Anu Kantele
Journal:  Clin Infect Dis       Date:  2012-06-13       Impact factor: 9.079

4.  Domestic pigs and Japanese encephalitis virus infection, Australia.

Authors:  Andrew F van-den-Hurk; Scott A Ritchie; Cheryl A Johansen; John S Mackenzie; Greg A Smith
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

5.  Long-term neurological and healthcare burden of adults with Japanese encephalitis: A nationwide study 2000-2015.

Authors:  Hsuan-Ying Chen; Chen-Yi Yang; Cheng-Yang Hsieh; Chun-Yin Yeh; Chang-Chun Chen; Yen-Chin Chen; Chung-Chih Lai; Rebecca Claire Harris; Huang-Tz Ou; Nai-Ying Ko; Wen-Chien Ko
Journal:  PLoS Negl Trop Dis       Date:  2021-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.